| pubmed-article:18701819 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18701819 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:18701819 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:18701819 | lifeskim:mentions | umls-concept:C0205223 | lld:lifeskim |
| pubmed-article:18701819 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:18701819 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
| pubmed-article:18701819 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18701819 | pubmed:dateCreated | 2008-8-27 | lld:pubmed |
| pubmed-article:18701819 | pubmed:abstractText | Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths. Difficulties to diagnose HCC at early stages remain the major obstacle to curative (surgical) therapy. Therapy in advanced stages has to be considered palliative. In this situation, a considerable amount of attention should be paid to innovative treatment strategies, e.g. including antiangiogenetic drugs. | lld:pubmed |
| pubmed-article:18701819 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18701819 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18701819 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18701819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18701819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18701819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18701819 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18701819 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18701819 | pubmed:issn | 1421-9794 | lld:pubmed |
| pubmed-article:18701819 | pubmed:author | pubmed-author:NaujoksKurtK | lld:pubmed |
| pubmed-article:18701819 | pubmed:author | pubmed-author:SchalhornAndr... | lld:pubmed |
| pubmed-article:18701819 | pubmed:author | pubmed-author:LenzGeorgG | lld:pubmed |
| pubmed-article:18701819 | pubmed:author | pubmed-author:Forstpointner... | lld:pubmed |
| pubmed-article:18701819 | pubmed:author | pubmed-author:KühnbachRober... | lld:pubmed |
| pubmed-article:18701819 | pubmed:author | pubmed-author:ChristopeitMa... | lld:pubmed |
| pubmed-article:18701819 | pubmed:author | pubmed-author:BartelheimKer... | lld:pubmed |
| pubmed-article:18701819 | pubmed:copyrightInfo | (c) 2008 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:18701819 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18701819 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:18701819 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18701819 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18701819 | pubmed:pagination | 309-14 | lld:pubmed |
| pubmed-article:18701819 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:meshHeading | pubmed-meshheading:18701819... | lld:pubmed |
| pubmed-article:18701819 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18701819 | pubmed:articleTitle | Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:18701819 | pubmed:affiliation | Department of Medicine IV, Oncology/Hematology, University Hospital Halle Saale, Halle Saale, Germany. | lld:pubmed |
| pubmed-article:18701819 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18701819 | pubmed:publicationType | Case Reports | lld:pubmed |
